A5101560476- Dermatology and Skin Diseases
- Hair Growth and Disorders
- Allergic Rhinitis and Sensitization
- Food Allergy and Anaphylaxis Research
- Bariatric Surgery and Outcomes
- Congenital Diaphragmatic Hernia Studies
- Body Contouring and Surgery
- Dermatologic Treatments and Research
- Complementary and Alternative Medicine Studies
- Circadian rhythm and melatonin
- Climate Change and Health Impacts
- Medicine and Dermatology Studies History
- Dermatological and COVID-19 studies
- Abdominal Trauma and Injuries
- Olfactory and Sensory Function Studies
- Esophageal and GI Pathology
- Colorectal Cancer Surgical Treatments
- Gastric Cancer Management and Outcomes
- Abdominal vascular conditions and treatments
- melanin and skin pigmentation
- Transgenic Plants and Applications
- Obesity and Health Practices
- Autoimmune Bullous Skin Diseases
- Skin Protection and Aging
- Asthma and respiratory diseases
Adelphi Group (United Kingdom)
2021-2025
Eisenhower Foundation
2025
University of Nevada, Las Vegas
2024
University of Toronto
2018
ABSTRACT Background Hair loss due to alopecia areata (AA) can negatively impact patients’ health‐related quality of life (HRQoL). Patient‐reported outcome measures (PROMs) like the EQ‐5D‐5L and Alopecia Areata Patient Priority Outcomes (AAPPO) represent treatment outcomes guide decision‐making. However, potentially underestimates AA‐specific impacts, while AAPPO may provide a more disease‐specific assessment. Objectives This study uses emotional symptom (ES) activity limitations (AL)...
A central — perhaps the challenge confronting political leaders and economic change makers in all our democracies is need for society-wide actions to minimise effects of climate change, tackle its root cause: reliance societies economies on fossil fuels. In US, UK, Germany, Sweden elsewhere Europe,1 a broad majority public wants see action address reverse impacts that also believes going green ameliorating can be source new jobs reinvigorate rural areas suffering from loss young people. Yet...
Vitiligo may negatively impact quality of life (QOL). This study aimed to classify patients on the basis vitiligo emotional/psychological and social functioning describe patient characteristics patient-reported outcome (PRO) responses for each profile. Physician surveys from Disease Specific Programme in France, Germany, Italy, Spain, USA were analyzed. PROs assessed using Patient Priority Outcomes (ViPPO), Work Productivity Activity Index-Vitiligo, Vitiligo-Specific Quality-of-Life...
ABSTRACT Atopic dermatitis ( AD ) is a common and burdensome disease. Treatment options for pediatric adolescent patients (< 18 years old) with moderate‐to‐severe are limited, real‐world data on disease burden lacking. This study examined patient‐reported treatments in to identify opportunities patient benefit. Data were drawn from the Adelphi Real World Pediatric Disease Specific Programme (DSP), cross‐sectional survey of physicians < old, conducted Europe United States between...
Patients with atopic dermatitis (AD) experience burdensome symptoms and impaired quality of life (QoL). The objective this study was to investigate the effects topical AD therapies on disease control, physician patient treatment satisfaction, QoL in a real-world setting.This retrospective, point-in-time physician-completed medical records surveys drawn from two Adelphi Disease Specific Programmes™ (1. adults ≥ 18 years old; 2. pediatrics ≤ 17 old) USA. Eligible physicians completed record...
Alopecia areata (AA) is an autoimmune disease that causes scalp, face, and/or body hair loss. Recently, oral treatments with kinases inhibition became the first approved therapies for severe AA. An understanding of use and effectiveness traditional in real-world treatment settings needed to guide integration novel into paradigm. This study aimed describe patterns, dermatologists' reasons therapy choice, satisfaction control among patients Data were drawn from 2021–2022 Adelphi Real World AA...
Atopic dermatitis (AD) is an inflammatory disease causing severe skin itching. Data on patient-physician disconnect treatment satisfaction in patients with AD Japan are limited. We investigated and if it influences patterns, clinical characteristics, patient-reported outcomes (PROs). were drawn from the Adelphi Disease Specific Programme (DSP), a real-world, point-in-time survey of physicians conducted April to July 2019. Patients grouped according level ("extremely satisfied" "extremely...
This study evaluated the level of burden in pediatric and adolescent atopic dermatitis (AD) patients Japan, associated on caregivers/families, whether this varied with age.
Data were drawn from the Adelphi Atopic Dermatitis Disease Specific Programme (DSP TM ), a multinational, point in time survey of physicians (dermatologists, allergists and PCPs) their consulting AD patients US (during 2018), Germany (2019), Italy UK France (2020) Spain (2021). The study used data adults aged ≥18 years with physician-assessed moderate-to-severe AD. Patient-Reported Outcomes Patients completed PRO questionnaires which they asked to select ongoing day-to-day symptoms...
■ Atopic dermatitis (AD) is a chronic heterogeneous inflammatory skin disorder characterised by pruritus and eczematous lesions AD has fluctuating disease pattern with many patients experiencing acute exacerbations often referred to as 'flares' 1.2■ Currently, real-world data on pediatric adolescent (≤17 years) are limited, the impact of reported burden, including flares, largely unquantified
Background: The COVID-19 pandemic is expected to have impacted patient management on a global level. However, the degree of impact and prescribing strategy in fields rheumatology, dermatology gastroenterology unclear. Objectives: Assess across EU US, as described by rheumatologists, dermatologists, gastroenterologists. Methods: Data were drawn from physician surveys France, Germany, Italy, Spain, UK US between July December 2020. Physicians completed an online or telephone survey assessing...